Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study

被引:0
|
作者
Semenchuk, Julie [1 ]
Naito, Yumi [2 ]
Charman, Susan C. [2 ]
Carr, Siobhan B. [3 ,4 ]
Cheng, Stephanie Y. [5 ]
Marshall, Bruce C. [6 ]
Faro, Albert [6 ]
Elbert, Alexander [6 ]
Gutierrez, Hector H. [7 ]
Goss, Christopher H. [8 ]
Karadag, Bulent [9 ]
Burgel, Pierre-Regis [10 ,11 ]
Colombo, Carla [12 ]
Salvatore, Marco [13 ,14 ]
Padoan, Rita [15 ]
Daneau, Geraldine [16 ]
Harutyunyan, Satenik [17 ]
Kashirskaya, Nataliya [18 ]
Kirwan, Laura [19 ]
Middleton, Peter G. [20 ]
Ruseckaite, Rasa [21 ]
de Monestrol, Isabelle [22 ]
Naehrlich, Lutz [23 ]
Mondejar-Lopez, Pedro [24 ]
Jung, Andreas [25 ]
van Rens, Jacqui [26 ]
Bakkeheim, Egil [27 ]
Orenti, Annalisa [28 ]
Ommen, Domenique Zomer-van [29 ]
da Silva-Filho, Luiz Vicente R. F. [30 ]
Fernandes, Flavia Fonseca [31 ,32 ]
Zampoli, Marco [33 ]
Stephenson, Anne L. [1 ]
机构
[1] St Michaels Hosp, Dept Respirol, Toronto, ON, Canada
[2] UK Trust, London, England
[3] Royal Brompton & Harefield Hosp, Guys & St Thomass NHS Fdn Trust, London, England
[4] Imperial Coll, London, England
[5] Cyst Fibrosis Canada, Toronto, ON, Canada
[6] Cyst Fibrosis Fdn, Bethesda, MD USA
[7] Univ Alabama Birmingham, Div Pediat Pulm & Sleep Med, Birmingham, AL USA
[8] Univ Washington, Dept Med, Div Pulm Crit Care & Sleep Med, Med Ctr, Seattle, WA USA
[9] Marmara Univ, Fac Med, Div Pediat Pulmonol, Istanbul, Turkiye
[10] Cochin Hosp, APHP, Natl Reference CF Ctr & Resp Med, Paris, France
[11] Univ Paris Cite, Inst Cochin InsermU1016, Paris, France
[12] Univ Milan, Fdn IRCCS CaGranda Osped Maggiore Policlin, Milan, Italy
[13] Natl Ctr Rare Dis, Undiagnosed Rare Dis Interdept Unit, Rome, Italy
[14] Ist Super Sanita, Italian CF, Rome, Italy
[15] Italian Cyst Fibrosis Registry, Sci Board, Rome, Italy
[16] Yerevan Univ, Muratsan Hosp, CF Ctr, Yerevan, Armenia
[17] Belgian Cyst Fibrosis Registry, Dept epidemiol & publ Hlth, Hlth Serv Res, Sciensano, Belgium
[18] Moscow Reg Res & Clin Inst MONIKI, Res Ctr Med Genet, Moscow, Russia
[19] Univ Coll Dublin, Cyst Fibrosis Registry Ireland, Woodview House, Dublin, Ireland
[20] Westmead Hosp, Dept Resp & Sleep Med, Bronchiectasis & CF Serv, Sydney, Australia
[21] Monash Univ, Dept Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[22] Karolinska Univ Hosp Huddinge, Karolinska Inst, Stockholm CF Ctr, Dept Pediat, Huddinge, Sweden
[23] Justus Liebig Univ Giessen, Dept Pediat, Giessen, Germany
[24] Hosp Clin Univ Virgen Arrixaca, Murcia, Spain
[25] Univ Childrens Hosp Zurich, Dept Pulmonol, Zurich, Switzerland
[26] Univ Hosp Leuven, Dept Paediat, Leuven, Belgium
[27] Oslo Univ Hosp, Natl Resource Ctr Cyst Fibrosis, Dept Paediat & Adolescent Med, Oslo, Norway
[28] Univ Milan, Dept Clin Sci & Community Hlth, Dipartimento Eccellenza 2023 2027, Lab Med Stat Biometry & Epidemiol G A Maccacaro, Milan, Italy
[29] Dutch CF Fdn NCFS, Baarn, Netherlands
[30] Inst Crianca & Adolescente HCFMUSP, Sao Paulo, Brazil
[31] Univ Fed Catalao, Med Dept, Catalao, Brazil
[32] Hosp Base Dist Fed, Brasilia, Brazil
[33] Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa
关键词
COVID-19; Coronavirus; Cystic fibrosis; SARS-COV-2; INFECTION; PEOPLE; CHILDREN;
D O I
10.1016/j.jcf.2024.07.019
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Factors associated with severe COVID-19 infection have been identified; however, the impact of infection on longer-term outcomes is unclear. The objective of this study was to examine the impact of COVID-19 infection on the trajectory of lung function and nutritional status in people with cystic fibrosis (pwCF). Methods This is a retrospective global cohort study of pwCF who had confirmed COVID-19 infection diagnosed between January 1, 2020 and December 31, 2021. Forced expiratory volume in one second percent predicted (ppFEV(1)) and body mass index (BMI) twelve months prior to and following a diagnosis of COVID-19 were recorded. Change in mean ppFEV(1) and BMI were compared using a t-test. A linear mixed-effects model was used to estimate change over time and to compare the rate of change before and after infection. Results A total of 6,500 cases of COVID-19 in pwCF from 33 countries were included for analysis. The mean difference in ppFEV(1) pre- and post-infection was 1.4 %, (95 % CI 1.1, 1.7). In those not on modulators, the difference in rate of change pre- and post-infection was 1.34 %, (95 % CI -0.88, 3.56) per year (p = 0.24) and -0.74 % (-1.89, 0.41) per year (p = 0.21) for those on elexacaftor/tezacaftor/ivacaftor. No clinically significant change was noted in BMI or BMI percentile before and after COVID-19 infection. Conclusions No clinically meaningful impact on lung function and BMI trajectory in the year following infection with COVID-19 was identified. This work highlights the ability of the global CF community to unify and address critical issues facing pwCF.
引用
收藏
页码:815 / 822
页数:8
相关论文
共 50 条
  • [1] UNDERSTANDING THE IMPACT OF COVID-19 ON INDIVIDUALS WITH CYSTIC FIBROSIS
    Rhoads, S. L.
    Auth, R.
    Blundin, M.
    Banerjee, D.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S161 - S162
  • [2] Impact of COVID-19 social distancing recommendations on pulmonary function, nutritional status, and morbidity in patients with cystic fibrosis
    Bagatini, Maria Amelia
    Heinzmann-Filho, Joao Paulo
    Vendrusculo, Fernanda Maria
    Pinto, Leonardo Araujo
    Donadio, Marcio Vinicius Fagundes
    REVISTA PAULISTA DE PEDIATRIA, 2024, 42
  • [3] COVID-19 lockdown beneficial effects on lung function in a cohort of cystic fibrosis patients
    Servidio, Alessia Giuseppina
    Capata, Giulia
    Levantino, Laura
    Riccio, Guglielmo
    Contorno, Sarah
    Barbi, Egidio
    Maschio, Massimo
    ITALIAN JOURNAL OF PEDIATRICS, 2021, 47 (01)
  • [4] COVID-19 lockdown beneficial effects on lung function in a cohort of cystic fibrosis patients
    Alessia Giuseppina Servidio
    Giulia Capata
    Laura Levantino
    Guglielmo Riccio
    Sarah Contorno
    Egidio Barbi
    Massimo Maschio
    Italian Journal of Pediatrics, 47
  • [5] Impact of nutritional status on pulmonary function after lung transplantation for cystic fibrosis
    Staufer, Katharina
    Halilbasic, Emina
    Hillebrand, Peter
    Harm, Solveig
    Schwarz, Stefan
    Jaksch, Peter
    Kivaranovic, Danijel
    Klepetko, Walter
    Trauner, Michael
    Kazemi-Shirazi, Lili
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (07) : 1049 - 1055
  • [6] The Impact of COVID-19 in Cystic Fibrosis
    Flume, Patrick A.
    Saiman, Lisa
    Marshall, Bruce
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (06): : 466 - 468
  • [7] Impact of COVID-19 Lockdown on Pulmonary and Nutritional Status in Children and Young Adults With Cystic Fibrosis, in Greece
    Loukou, Ioanna
    Moustaki, Maria
    Petrocheilou, Argyri
    Zarkada, Ioanna
    Douros, Konstantinos
    JOURNAL OF PATIENT EXPERIENCE, 2021, 8
  • [8] Impact of COVID-19 on people with cystic fibrosis
    Colombo, Carla
    Burgel, Pierre-Regis
    Gartner, Silvia
    van Koningsbruggen-Rietschel, Silke
    Naehrlich, Lutz
    Sermet-Gaudelus, Isabelle
    Southern, Kevin W.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (05): : E35 - E36
  • [9] Early COVID-19 infection after lung transplantation in a patient with cystic fibrosis
    Athanazio, Rodrigo Abensur
    Costa, Andre Nathan
    Carraro, Rafael Medeiros
    Gonzalez, Diego
    Rached, Samia Zahi
    Samano, Marcos Naoyuki
    de Oliveira Braga Teixeira, Ricardo Henrique
    Campos, Silvia Vidal
    CLINICS, 2020, 75
  • [10] CHILDREN WITH BRONCHIECTASIS HAVE REDUCED LUNG FUNCTION AND POORER NUTRITIONAL STATUS THAN THEIR CYSTIC FIBROSIS COHORT
    Prentice, B.
    Wales, S.
    Widger, J.
    RESPIROLOGY, 2016, 21 : 53 - 53